Kirill V. Lepik - Concepedia

Author

Kirill V. Lepik

First Pavlov State Medical University of St. Petersburg ORCID

Also Known As

K V. Lepik, K. Lepik, K. V. Lepik, K.V. Lepik, Kirill Lepik, Kirill V Lepik, Kirill V. Lepik, Kirill Viktorovich Lepik, M. O. Popova

137

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

First Pavlov State Medical University of St. Petersburg Peter the Great St. Petersburg Polytechnic University Queen Mary University of London National Research Tomsk State University Tomsk Polytechnic University

About

Kirill V. Lepik is an author at First Pavlov State Medical University of St. Petersburg specializing in medicine, engineering, and biomedical engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	524
2	Engineering	9	9	456
3	Biomedical Engineering	9	9	456
4	Health Sciences	3	3	66
5	Biomolecular Engineering	2	2	157

Kirill V. Lepik

Publications

747

Citations

H-Index

Page 1

	Year	Citations
A comparison study between electrospun polycaprolactone and piezoelectric poly(3-hydroxybutyrate-co-3-hydroxyvalerate) scaffolds for bone tissue engineering Аlbert R. Muslimov, Dina S. Syromotina, Alexander S. Timin, Colloids and Surfaces B Biointerfaces Tissue EngineeringRegenerative MedicinePiezoelectric PolySynthetic Bone SubstituteEngineering	2017	139
Efficient gene editing via non-viral delivery of CRISPR–Cas9 system using polymeric and hybrid microcarriers Alexander S. Timin, Аlbert R. Muslimov, Kirill V. Lepik, Nanomedicine Nanotechnology Biology and Medicine EngineeringCell ModificationGenetic EngineeringCrispr–cas9 SystemEfficient Gene	2017	111
Safe and Effective Delivery of Antitumor Drug Using Mesenchymal Stem Cells Impregnated with Submicron Carriers Alexander S. Timin, Oleksii O. Peltek, Mikhail V. Zyuzin, ACS Applied Materials & Interfaces Cell TherapyEngineeringBiomedical EngineeringTumor BiologyCancer Engineering	2019	53
Hybrid inorganic-organic capsules for efficient intracellular delivery of novel siRNAs against influenza A (H1N1) virus infection Alexander S. Timin, Аlbert R. Muslimov, Aleksandra V. Petrova, Scientific Reports NanoparticlesNanomedicineHybrid Inorganic-organic CapsulesEngineeringVirus Infection	2017	46
Triple-responsive inorganic–organic hybrid microcapsules as a biocompatible smart platform for the delivery of small molecules Alexander S. Timin, Аlbert R. Muslimov, Kirill V. Lepik, Journal of Materials Chemistry B	2016	35
Mesenchymal Stem Cell Magnetization: Magnetic Multilayer Microcapsule Uptake, Toxicity, Impact on Functional Properties, and Perspectives for Magnetic Delivery Kirill V. Lepik, Аlbert R. Muslimov, Alexander S. Timin, Advanced Healthcare Materials NanoparticlesTissue EngineeringMagnetic PropertiesFunctional PropertiesEngineering	2016	35
A Phase 2 Study of Nivolumab Using a Fixed Dose of 40 mg (Nivo40) in Patients With Relapsed/Refractory Hodgkin Lymphoma Kirill V. Lepik, Liudmila Fedorova, Elena Kondakova, HemaSphere Surgical OncologyRelapsed/refractory Hodgkin LymphomaFixed DosePharmacotherapyMetronomic Chemotherapy	2020	34
Intracellular Breakable and Ultrasound-Responsive Hybrid Microsized Containers for Selective Drug Release into Cancerous Cells Alexander S. Timin, Аlbert R. Muslimov, Kirill V. Lepik, Particle & Particle Systems Characterization Cell-based Drug DeliveryNanomedicineIntracellular BreakableSuch Hybrid CapsulesEngineering	2017	29
A highly efficient and safe gene delivery platform based on polyelectrolyte core–shell nanoparticles for hard-to-transfect clinically relevant cell types Yana V. Tarakanchikova, Igor S. Sergeev, Kirill V. Lepik, Journal of Materials Chemistry B	2020	27
A Study of Safety and Efficacy of Nivolumab and Bendamustine (NB) in Patients With Relapsed/Refractory Hodgkin Lymphoma After Nivolumab Monotherapy Failure Kirill V. Lepik, N.B. Mikhailova, Elena Kondakova, HemaSphere	2020	26

Page 1